COF vs RNTX · P/E 62, rev $53.43B vs $80.6M cap
Capital One Financial Corporation (COF) versus Rein Therapeutics Inc (RNTX) — a side-by-side from cached financials, not a winner call.
Capital One Financial Corporation (COF) is a credit services company listed on NYSE.
Rein Therapeutics Inc (RNTX) is a biotechnology company listed on NASDAQ.
Latest reported COF revenue for 2025-12-31 was $53.43B. Net income was $2.45B. Revenue was up 36.6% from 2024-12-31 to 2025-12-31. COF currently screens at market cap $125.00B and trailing P/E 61.8.
Latest reported RNTX revenue for 2026-06-30 was $0. Net income was -$12.2M. RNTX currently screens at market cap $80.6M.
COF currently screens at market cap $125.00B and trailing P/E 61.8. RNTX currently screens at market cap $80.6M.
Not investment advice. Open the COF and RNTX stock pages for the full models.
Not investment advice.